Tiziana Life Sciences strengthens intranasal foralumab development with Renaissance Lakewood partnership

Pallavi Madhiraju- February 23, 2025 0

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA), a clinical-stage biotechnology company focused on immunomodulation therapies, has announced a strategic partnership with Renaissance Lakewood LLC, a leading ... Read More

Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19

pallavi123- March 30, 2021 0

Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal administration of Foralumab in moderate to severe ... Read More